Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seynaeve

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancerR de Wit, M Tesselaar, T C Kok, et al.
British Journal of Cancer|August 1, 1991
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistanceJ Verweij, H Herweijer, R Oosterom, et al.
British Journal of Cancer|July 1, 1992
Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study GroupC Seynaeve, J Schuller, K Buser, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2003
Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancerC H Smorenburg, A J ten Tije, J Verweij, et al.
The British Journal of Surgery|June 8, 2006
Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancerM M A Tilanus-Linthorst, C Alves, C Seynaeve, et al.
Annals of Internal Medicine|December 1, 1990
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover studyP H De Mulder, C Seynaeve, J B Vermorken, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 20, 2005
[Preventive surgical prcedures for inherited risk of breast cancer]M B E Menke-Pluymers, C Seynaeve, A N van Geel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumoursJ-Y Blay, A Le Cesne, J Verweij, et al.
Psycho-Oncology|February 4, 2009
The Distress Thermometer assessed in women at risk of developing hereditary breast cancerS van Dooren, H J Duivenvoorden, J Passchier, et al.
Community Genetics|August 28, 2004
Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancerS van Dooren, A J Rijnsburger, C Seynaeve, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancerR de Wit, M Tesselaar, T C Kok, et al.
British Journal of Cancer|August 1, 1991
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistanceJ Verweij, H Herweijer, R Oosterom, et al.
British Journal of Cancer|July 1, 1992
Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study GroupC Seynaeve, J Schuller, K Buser, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2003
Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancerC H Smorenburg, A J ten Tije, J Verweij, et al.
The British Journal of Surgery|June 8, 2006
Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancerM M A Tilanus-Linthorst, C Alves, C Seynaeve, et al.
Annals of Internal Medicine|December 1, 1990
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover studyP H De Mulder, C Seynaeve, J B Vermorken, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 20, 2005
[Preventive surgical prcedures for inherited risk of breast cancer]M B E Menke-Pluymers, C Seynaeve, A N van Geel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumoursJ-Y Blay, A Le Cesne, J Verweij, et al.
Psycho-Oncology|February 4, 2009
The Distress Thermometer assessed in women at risk of developing hereditary breast cancerS van Dooren, H J Duivenvoorden, J Passchier, et al.
Community Genetics|August 28, 2004
Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancerS van Dooren, A J Rijnsburger, C Seynaeve, et al.
Pageof 11